Australia & New Zealand Research Antibodies Market Size, Share, & Trends Analysis Report By Product (Primary), By Type (Monoclonal), By Technology (Western Blotting), By Source (Mouse), By Application (Oncology), By End Use, And Segment Forecasts, 2019 - 2026

Published: Sep, 2019 | Pages: 51 | Publisher: Grand View Research
Industry: Biotechnology | Report Format: Electronic (PDF)

The Australia & New Zealand research antibodies market size is expected to reach USD 186.6 million by 2026 according to a new report by Grand View Research, Inc., exhibiting a CAGR of 8.4%. Drivers of this market include rise in R&D initiatives being undertaken by biopharmaceutical & biotechnology companies, increase in government investments on R&D, and growth in neurobiology & stem cell research.

Rise in R&D investments and research activities by various pharmaceutical and biotechnology companies to develop new & innovative products is anticipated to fuel market growth. For instance, in March 2019, the Federal Government invested USD 150 million in Stem Cells Australia and University of Melbourne to support R&D pertaining to stem cell and explore new ways to treat various life-threatening conditions such as stroke, congenital heart disease, and kidney disease.

Growth in stem cell and neurobiology-based research is expected to boost the market during the forecast period. There are a number of neurobiology-based research institutes in Australia. For instance, the Center of Research Excellence in Neuromuscular Disorders, Australia, is a collaboration between neuromuscular experts.

Ongoing launch of new products is anticipated to fuel market growth over the forecast period. For instance, in April 2019, Bio-Rad launched a range of isotype-specific secondary antibodies-IgG1, IgG2a, and IgG2b. These products are used for specificity in ELISA, imaging, western blotting, and flow cytometry as well as to improve signaling.

Increasing adoption of strategies, such as collaborations and acquisitions, by leading market players is expected to fuel market growth. For instance, in March 2016, Thermo Fisher Scientific Inc., announced the acquisition of Affymetrix, Inc. This strategic acquisition was aimed at strengthening the company's position in the field of bioscience and expanding its portfolio of antibodies.

New Zealand has been investing heavily in R&D in order to promote trade in biotechnology sector. According to Research, Science and Innovation System Performance Report, the nation's total expenditure on R&D was estimated to be 1.23% of GDP in 2016. This was funded by both public and private firms in New Zealand. Data from the same source also indicates that the country's science system is highly productive in terms of publications per researcher, with over USD 653,400 spent on research and higher education.

Further key findings from the report suggest:

• Primary antibodies held dominant share of the product segment in 2018. This can be attributed to wide applications of these antibodies in research

• Monoclonal antibodies held significant share of the type segment in 2018, mainly due to their efficient staining properties and high specificity for detection of antigens

• Western blotting held the largest share of the technology segment owing to rising demand for rapid diagnostic methods

• On the basis of technology, ELISA is anticipated to witness the highest CAGR during the forecast period, owing to conventional use of polyclonal antibodies for sandwich ELISA

• On the basis of source, mouse segment held the largest share of the Australia & New Zealand research antibodies market in 2018, as mice are convenient to use during production of antibodies for research purposes.

 Table of Contents

Chapter 1 Methodology and Scope
                    1.1 Market Segmentation & Scope
                    1.2 Market Definition
                    1.3 Information Procurement
                    1.4 Purchased Database
                    1.5 GVR's Internal Database
                    1.6 Secondary Sources & Third-party Perspectives
                    1.7 Primary Research
                    1.8 Information Analysis
                    1.9 Data Analysis Models
                    1.10 Market Formulation & Data Visualization
                    1.11 Data Validation & Publishing
Chapter 2 Executive Summary
                    2.1 Market Outlook
                    2.2 Segment Outlook
                    2.3 Competitive Insights
Chapter 3 Australia & New Zealand Research Antibodies Market Variables, Trends, & Scope
                    3.1 Market Lineage Outlook
                        3.1.1 Parent Market Outlook
                        3.1.2 Ancillary Market Outlook
                    3.2 Penetration And Growth Prospect Mapping
                        3.2.1 User Perspective Analysis
                            3.2.1.1 Consumer behavior analysis
                    3.3 Regulatory Framework
                        3.3.1 Reimbursement Framework
                        3.3.2 Standards And Compliances
                    3.4 Market Dynamics
                        3.4.1 Market Driver Analysis
                            3.4.1.1 Increasing investment in R&D
                            3.4.1.2 Growing stem cells and neurobiology research
                        3.4.2 Market Restraint Analysis
                            3.4.2.1 Stringent government regulations
                    3.5 Australia & New Zealand Research Antibodies Market Analysis Tools
                        3.5.1 Industry Analysis - Porter's
                            3.5.1.1 Supplier Power
                            3.5.1.2 Buyer Power
                            3.5.1.3 Substitution Threat
                            3.5.1.4 Threat from new entrants
                            3.5.1.5 Competitive Rivalry
                        3.5.2 Pestel Analysis
                            3.5.2.1 Political Landscape
                            3.5.2.2 Environmental Landscape
                            3.5.2.3 Social Landscape
                            3.5.2.4 Services Landscape
                            3.5.2.5 Legal Landscape
                        3.5.3 Major Deals And Strategic Alliances Analysis
                            3.5.3.1 Joint ventures
                            3.5.3.2 Mergers and acquisitions
                            3.5.3.3 Licensing and partnership
                            3.5.3.4 Services collaborations
                            3.5.3.5 Strategic Divestments
Chapter 4 Australia & New Zealand Research Antibodies Market - Competitive Analysis
                    4.1 Recent Developments & Impact Analysis, by Key Market Participants
                    4.2 Company Categorization
                        4.2.1 List Of Key Distributors And Channel Partners
                        4.2.2 Key Company Market Share Analysis, 2018
                    4.3 Public Companies
                        4.3.1 Company Market Position Analysis
                    4.4 Private Companies
                        4.4.1 List Of Key Emerging Companies
                        4.4.2 Regional Network Map
                        4.4.3 Company Market Position Analysis
Chapter 5 Australia & New Zealand Research Antibodies Market: Product Estimates and Trend Analysis
                    5.1 Definition & Scope
                    5.2 Product Market Share Analysis, 2018 & 2026
                    5.3 Segment Dashboard
                    5.4 Australia Research Antibodies Market, by Product, 2015 to 2026
                    5.5 Australia Market Size & Forecasts and Trend Analyses, 2015 to 2026
                    5.6 Primary Antibodies
                        5.6.1 Primary Antibodies Market, 2015 To 2026 (USD Million)
                    5.7 Secondary Antibodies
                        5.7.1 Secondary Antibodies Market, 2015 To 2026 (USD Million)
                    5.8 New Zealand Research Antibodies Market, By Product, 2015 To 2026
                    5.9 New Zealand Market Size & Forecasts And Trend Analyses, 2015 To 2026
                    5.10 Primary Antibodies
                        5.10.1 Primary Antibodies Market, 2015 To 2026 (USD Million)
                    5.11 Secondary Antibodies
                        5.11.1 Secondary Antibodies Market, 2015 To 2026 (USD Million)
Chapter 6 Australia & New Zealand Research Antibodies Market: Type Estimates and Trend Analysis
                    6.1 Definition & Scope
                    6.2 Type Market Share Analysis, 2018 & 2026
                    6.3 Segment Dashboard
                    6.4 Australia Research Antibodies Market, by Type, 2015 to 2026
                    6.5 Australia Market Size & Forecasts and Trend Analyses, 2015 to 2026
                    6.6 Monoclonal Antibodies
                        6.6.1 Monoclonal Antibodies Market, 2015 To 2026 (USD Million)
                    6.7 Polyclonal Antibodies
                        6.7.1 Polyclonal Antibodies Market, 2015 To 2026 (USD Million)
                    6.8 New Zealand Research Antibodies Market, by Type, 2015 to 2026
                    6.9 New Zealand Market Size & Forecasts and Trend Analyses, 2015 to 2026
                    6.10 Monoclonal Antibodies
                        6.10.1 Monoclonal Antibodies Market, 2015 To 2026 (USD Million)
                    6.11 Polyclonal Antibodies
                        6.11.1 Polyclonal Antibodies Market, 2015 To 2026 (USD Million)
Chapter 7 Australia & New Zealand Research Antibodies Market: Technology Estimates and Trend Analysis
                    7.1 Definition & Scope
                    7.2 Technology Market Share Analysis, 2018 & 2026
                    7.3 Segment Dashboard
                    7.4 Australia Research Antibodies Market, by Technology, 2015 to 2026
                    7.5 Australia Market Size & Forecasts and Trend Analyses, 2015 to 2026
                    7.6 Immunohistochemistry
                        7.6.1 Immunohistochemistry Market, 2015 To 2026 (USD Million)
                    7.7 Immunofluorescence
                        7.7.1 Immunofluorescence Market, 2015 To 2026 (USD Million)
                    7.8 Western Blotting
                        7.8.1 Western Blotting Market, 2015 To 2026 (USD Million)
                    7.9 Flow Cytometry
                        7.9.1 Flow Cytometry Market, 2015 To 2026 (USD Million)
                    7.10 Immunoprecipitation
                        7.10.1 Immunoprecipitation Market, 2015 To 2026 (USD Million)
                    7.11 Elisa
                        7.11.1 Elisa Market, 2015 To 2026 (USD Million)
                    7.12 Others
                        7.12.1 Others Market, 2015 To 2026 (USD Million)
                    7.13 New Zealand Research Antibodies Market, by Technology, 2015 to 2026
                    7.14 New Zealand Market Size & Forecasts and Trend Analyses, 2015 to 2026
                    7.15 Immunohistochemistry
                        7.15.1 Immunohistochemistry Market, 2015 To 2026 (USD Million)
                    7.16 Immunofluorescence
                        7.16.1 Immunofluorescence Market, 2015 To 2026 (USD Million)
                    7.17 Western Blotting
                        7.17.1 Western Blotting Market, 2015 To 2026 (USD Million)
                    7.18 Flow Cytometry
                        7.18.1 Flow Cytometry Market, 2015 To 2026 (USD Million)
                    7.19 Immunoprecipitation
                        7.19.1 Immunoprecipitation Market, 2015 To 2026 (USD Million)
                    7.20 Elisa
                        7.20.1 Elisa Market, 2015 To 2026 (USD Million)
                    7.21 Others
                        7.21.1 Others Market, 2015 To 2026 (USD Million)
Chapter 8 Australia & New Zealand Research Antibodies Market: Source Estimates and Trend Analysis
                    8.1 Definition & Scope
                    8.2 Source Market Share Analysis, 2018 & 2026
                    8.3 Segment Dashboard
                    8.4 Australia Research Antibodies Market, by Source, 2015 to 2026
                    8.5 Australia Market Size & Forecasts and Trend Analyses, 2015 to 2026
                    8.6 Mouse
                        8.6.1 Mouse Market, 2015 To 2026 (USD Million)
                    8.7 Rabbit
                        8.7.1 Rabbit Market, 2015 To 2026 (USD Million)
                    8.8 Goat
                        8.8.1 Goat Market, 2015 To 2026 (USD Million)
                    8.9 Other Research Antibodies
                        8.9.1 Other Research Antibodies Market, 2015 To 2026 (USD Million)
                    8.10 New Zealand Research Antibodies Market, by Type, 2015 to 2026
                    8.11 New Zealand Market Size & Forecasts and Trend Analyses, 2015 to 2026
                    8.12 Mouse
                        8.12.1 Mouse Market, 2015 To 2026 (USD Million)
                    8.13 Rabbit
                        8.13.1 Rabbit Market, 2015 To 2026 (USD Million)
                    8.14 Goat
                        8.14.1 Goat Market, 2015 To 2026 (USD Million)
                    8.15 Other Research Antibodies
                        8.15.1 Other Research Antibodies Market, 2015 To 2026 (USD Million)
Chapter 9 Australia & New Zealand Research Antibodies Market: Application Estimates and Trend Analysis
                    9.1 Definition & Scope
                    9.2 Application Market Share Analysis, 2018 & 2026
                    9.3 Segment Dashboard
                    9.4 Australia Research Antibodies Market, by Application, 2015 to 2026
                    9.5 Australia Market Size & Forecasts and Trend Analyses, 2015 to 2026
                    9.6 Infectious Diseases
                        9.6.1 Infectious Diseases Market, 2015 To 2026 (USD Million)
                    9.7 Immunology
                        9.7.1 Immunology Market, 2015 To 2026 (USD Million)
                    9.8 Oncology
                        9.8.1 Oncology Market, 2015 To 2026 (USD Million)
                    9.9 Stem Cells
                        9.9.1 Stem Cells Market, 2015 To 2026 (USD Million)
                    9.10 Neurobiology
                        9.10.1 Neurobiology Market, 2015 To 2026 (USD Million)
                    9.11 Other Applications
                        9.11.1 Other Applications Market, 2015 To 2026 (USD Million)
                    9.12 New Zealand Research Antibodies Market, By Application, 2015 To 2026
                    9.13 New Zealand Market Size & Forecasts And Trend Analyses, 2015 To 2026
                    9.14 Infectious Diseases
                        9.14.1 Infectious Diseases Market, 2015 To 2026 (USD Million)
                    9.15 Immunology
                        9.15.1 Immunology Market, 2015 To 2026 (USD Million)
                    9.16 Oncology
                        9.16.1 Oncology Market, 2015 To 2026 (USD Million)
                    9.17 Stem Cells
                        9.17.1 Stem Cells Market, 2015 To 2026 (USD Million)
                    9.18 Neurobiology
                        9.18.1 Neurobiology Market, 2015 To 2026 (USD Million)
                    9.19 Other Applications
                        9.19.1 Other Applications Market, 2015 To 2026 (USD Million)
Chapter 10 Australia & New Zealand Research Antibodies Market: End-use Estimates and Trend Analysis
                    10.1 Definition & Scope
                    10.2 End-use Market Share Analysis, 2018 & 2026
                    10.3 Segment Dashboard
                    10.4 Australia Research Antibodies Market, by End Use, 2015 to 2026
                    10.5 Australia Market Size & Forecasts and Trend Analyses, 2015 to 2026
                    10.6 Academic & Research Institutes
                        10.6.1 Academic & Research Institutes Market, 2015 To 2026 (USD Million)
                    10.7 Contract Research Organizations
                        10.7.1 Contract Research Organizations Market, 2015 To 2026 (USD Million)
                    10.8 Pharmaceutical & Biotechnological Companies
                        10.8.1 Pharmaceutical & Biotechnological Companies Market, 2015 To 2026 (USD Million)
                    10.9 New Zealand Research Antibodies Market, By End Use, 2015 To 2026
                    10.10 New Zealand Market Size & Forecasts And Trend Analyses, 2015 To 2026
                    10.11 Academic & Research Institutes
                        10.11.1 Academic & Research Institutes Market, 2015 To 2026 (USD Million)
                    10.12 Contract Research Organizations
                        10.12.1 Contract Research Organizations Market, 2015 To 2026 (USD Million)
                    10.13 Pharmaceutical & Biotechnological Companies
                        10.13.1 Pharmaceutical & Biotechnological Companies Market, 2015 To 2026 (USD Million)
Chapter 11 Australia & New Zealand Research Antibodies Market: Regional Estimates & Trend Analysis
                    11.1 Regional Market Snapshot
                    11.2 Market Share Analysis By Country, 2018
                        11.2.1 Australia
                        11.2.2 New Zealand
                    11.3 Swot Analysis, By Factor (Political & Legal, Economic And Technological)
                        11.3.1 Australia
                        11.3.2 New Zealand
                    11.4 Market Size & Forecasts, and Trend Analysis, 2018 to 2026
                        11.4.1 Australia
                            11.4.1.1 Market Size & Forecasts And Trend Analysis, By Product, 2015 To 2026 (USD Million)
                            11.4.1.2 Market Size & Forecasts And Trend Analysis, By Type, 2015 To 2026 (USD Million)
                            11.4.1.3 Market Size & Forecasts And Trend Analysis, By Technology, 2015 To 2026 (USD Million)
                            11.4.1.4 Market Size & Forecasts And Trend Analysis, By Source, 2015 To 2026 (USD Million)
                            11.4.1.5 Market Size & Forecasts And Trend Analysis, By Application, 2015 To 2026 (USD Million)
                            11.4.1.6 Market Size & Forecasts And Trend Analysis, By End Use, 2015 To 2026 (USD Million)
                        11.4.2 New Zealand
                            11.4.2.1 Market Size & Forecasts And Trend Analysis, By Product, 2015 To 2026 (USD Million)
                            11.4.2.2 Market Size & Forecasts And Trend Analysis, By Type, 2015 To 2026 (USD Million)
                            11.4.2.3 Market Size & Forecasts And Trend Analysis, By Technology, 2015 To 2026 (USD Million)
                            11.4.2.4 Market Size & Forecasts And Trend Analysis, By Source, 2015 To 2026 (USD Million)
                            11.4.2.5 Market Size & Forecasts And Trend Analysis, By Application, 2015 To 2026 (USD Million)
                            11.4.2.6 Market Size & Forecasts And Trend Analysis, By End Use, 2015 To 2026 (USD Million)
Chapter 12 Company Profiles
                    12.1 Company Profiles
                        12.1.1 ABCAM PLC
                            12.1.1.1 Company overview
                            12.1.1.2 Financial performance
                            12.1.1.3 Product benchmarking
                            12.1.1.4 Strategic initiatives
                        12.1.2 BIO-RAD LABORATORIES
                            12.1.2.1 Company overview
                            12.1.2.2 Financial performance
                            12.1.2.3 Product benchmarking
                            12.1.2.4 Strategic initiatives
                        12.1.3 BD
                            12.1.3.1 Company overview
                            12.1.3.2 Financial performance
                            12.1.3.3 Product benchmarking
                            12.1.3.4 Strategic initiatives
                        12.1.4 MERCK MILLIPORE (DANAHER)
                            12.1.4.1 Company overview
                            12.1.4.2 Financial performance
                            12.1.4.3 Product benchmarking
                            12.1.4.4 Strategic initiatives
                        12.1.5 LONZA GROUP
                            12.1.5.1 Company overview
                            12.1.5.2 Financial performance
                            12.1.5.3 Product benchmarking
                            12.1.5.4 Strategic initiatives
                        12.1.6 THERMO FISHER SCIENTIFIC
                            12.1.6.1 Company overview
                            12.1.6.2 Financial performance
                            12.1.6.3 Product benchmarking
                            12.1.6.4 Strategic initiatives
                        12.1.7 CELL SIGNALING TECHNOLOGY, INC.
                            12.1.7.1 Company overview
                            12.1.7.2 Financial performance
                            12.1.7.3 Product benchmarking
                            12.1.7.4 Strategic initiatives
                        12.1.8 F.HOFFMANN LA ROCHE LTD.
                            12.1.8.1 Company overview
                            12.1.8.2 Financial performance
                            12.1.8.3 Product benchmarking
                            12.1.8.4 Strategic initiatives
                        12.1.9 AGILENT TECHNOLOGIES
                            12.1.9.1 Company overview
                            12.1.9.2 Financial performance
                            12.1.9.3 Product benchmarking
                            12.1.9.4 Strategic initiatives
                        12.1.10 PERKINELMER, INC.
                            12.1.10.1 Company overview
                            12.1.10.2 Financial performance
                            12.1.10.3 Product benchmarking
                            12.1.10.4 Strategic initiative

List of Tables

Table 1 List of key distributors and channel partners
Table 2 List of key emerging companies/product disruptors/innovators
Table 3 Australia research antibodies market, by product, 2015 - 2026 (USD Million)
Table 4 Australia research antibodies market, by antibody type, 2015 - 2026 (USD Million)
Table 5 Australia research antibodies market, by technology, 2015 - 2026 (USD Million)
Table 6 Australia research antibodies market, by source 2015 - 2026 (USD Million)
Table 7 Australia research antibodies market, by application 2015 - 2026 (USD Million)
Table 8 Australia research antibodies market, by end use 2015 - 2026 (USD Million)
Table 9 New Zealand research antibodies market, by product 2015 - 2026 (USD Million)
Table 10 New Zealand research antibodies market, by antibody type 2015 - 2026 (USD Million)
Table 11 New Zealand research antibodies market, by technology 2015 - 2026 (USD Million)
Table 12 New Zealand research antibodies market, by source 2015 - 2026 (USD Million)
Table 13 New Zealand research antibodies market, by application 2015 - 2026 (USD Million)
Table 14 New Zealand research antibodies market, by end use 2015 - 2026 (USD Million)

List of Figures

Fig. 1 Australia & New Zealand research antibodies market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain based sizing & forecasting
Fig. 7 Australia & New Zealand research antibodies market snapshot (2018)
Fig. 8 Australia & New Zealand research antibodies market: Segment snapshot (2018)
Fig. 9 Competitive insights (2018)
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Australia & New Zealand research antibodies market driver impact
Fig. 15 Australia & New Zealand research antibodies market restraint impact
Fig. 16 Porter's five forces analysis
Fig. 17 SWOT analysis, by factor (political & legal economic and technological)
Fig. 18 Strategic alliance analysis
Fig. 19 Recent developments & impact analysis, by key market participants
Fig. 20 Key company market share analysis, 2018
Fig. 21 Company market share/ranking, by region
Fig. 22 Company market position analysis
Fig. 23 Definition and scope, by product
Fig. 24 Product market share analysis, 2018 & 2026
Fig. 25 Segment dashboard
Fig. 26 Australia research antibodies market, by product, 2015 - 2026 (USD Million)
Fig. 27 Australia primary antibodies market, 2015 - 2026 (USD Million)
Fig. 28 Australia secondary antibodies market, 2015 - 2026 (USD Million)
Fig. 29 New Zealand research antibodies market, by product, 2015 - 2026 (USD Million)
Fig. 30 New Zealand primary antibodies market, 2015 - 2026 (USD Million)
Fig. 31 New Zealand secondary antibodies market, 2015 - 2026 (USD Million)
Fig. 32 Australia research antibodies market, by type market, 2015 - 2026 (USD Million)
Fig. 33 Australia monoclonal antibodies market, 2015 - 2026 (USD Million)
Fig. 34 Australia polyclonal antibodies market, 2015 - 2026 (USD Million)
Fig. 35 New Zealand research antibodies market, by type market, 2015 - 2026 (USD Million)
Fig. 36 New Zealand monoclonal antibodies market, 2015 - 2026 (USD Million)
Fig. 37 New Zealand polyclonal antibodies market, 2015 - 2026 (USD Million)
Fig. 38 Australia research antibodies market, by technology market, 2015 - 2026 (USD Million)
Fig. 39 Australia immunohistochemistry market, 2015 - 2026 (USD Million)
Fig. 40 Australia immunofluorescence market, 2015 - 2026 (USD Million)
Fig. 41 Australia Western blotting market, 2015 - 2026 (USD Million)
Fig. 42 Australia flow cytometry market, 2015 - 2026 (USD Million
Fig. 43 Australia immunoprecipitation market, 2015 - 2026 (USD Million
Fig. 44 Australia enzyme-linked immunoassay market, 2015 - 2026 (USD Million
Fig. 45 Australia others market, 2015 - 2026 (USD Million
Fig. 46 New Zealand research antibodies market, by technology market, 2015 - 2026 (USD Million)
Fig. 47 New Zealand immunohistochemistry market, 2015 - 2026 (USD Million)
Fig. 48 New Zealand immunofluorescence market, 2015 - 2026 (USD Million)
Fig. 49 New Zealand western blotting market, 2015 - 2026 (USD Million)
Fig. 50 New Zealand flow cytometry market, 2015 - 2026 (USD Million
Fig. 51 New Zealand immunoprecipitation market, 2015 - 2026 (USD Million
Fig. 52 New Zealand enzyme-linked immunoassay market, 2015 - 2026 (USD Million
Fig. 53 New Zealand others market, 2015 - 2026 (USD Million
Fig. 54 Australia research antibodies market, by source market, 2015 - 2026 (USD Million)
Fig. 55 Australia mouse market, 2015 - 2026 (USD Million)
Fig. 56 Australia rabbit market, 2015 - 2026 (USD Million)
Fig. 57 Australia goat market, 2015 - 2026 (USD Million)
Fig. 58 Australia other sources market, 2015 - 2026 (USD Million)
Fig. 59 New Zealand research antibodies market, by source market, 2015 - 2026 (USD Million)
Fig. 60 New Zealand mouse market, 2015 - 2026 (USD Million)
Fig. 61 New Zealand rabbit market, 2015 - 2026 (USD Million)
Fig. 62 New Zealand goat market, 2015 - 2026 (USD Million)
Fig. 63 New Zealand other sources market, 2015 - 2026 (USD Million)
Fig. 64 Australia research antibodies market, by application market, 2015 - 2026 (USD Million)
Fig. 65 Australia infectious diseases market, 2015 - 2026 (USD Million)
Fig. 66 Australia immunology market, 2015 - 2026 (USD Million)
Fig. 67 Australia oncology market, 2015 - 2026 (USD Million)
Fig. 68 Australia stem cells market, 2015 - 2026 (USD Million)
Fig. 69 Australia neurobiology market, 2015 - 2026 (USD Million)
Fig. 70 Australia other end users market, 2015 - 2026 (USD Million)
Fig. 71 New Zealand research antibodies market, by application market, 2015 - 2026 (USD Million)
Fig. 72 New Zealand infectious diseases market, 2015 - 2026 (USD Million)
Fig. 73 New Zealand immunology market, 2015 - 2026 (USD Million)
Fig. 74 New Zealand oncology market, 2015 - 2026 (USD Million)
Fig. 75 New Zealand stem cells market, 2015 - 2026 (USD Million)
Fig. 76 New Zealand neurobiology market, 2015 - 2026 (USD Million)
Fig. 77 New Zealand other end users market, 2015 - 2026 (USD Million)
Fig. 78 Australia research antibodies market, by end use market, 2015 - 2026 (USD Million)
Fig. 79 Australia academic & research institutes market, 2015 - 2026 (USD Million)
Fig. 80 Australia contract research organizations market, 2015 - 2026 (USD Million)
Fig. 81 Australia pharmaceutical & biotechnological companies market, 2015 - 2026 (USD Million)
Fig. 82 New Zealand research antibodies market, by end use market, 2015 - 2026 (USD Million)
Fig. 83 New Zealand academic & research institutes market, 2015 - 2026 (USD Million)
Fig. 84 New Zealand contract research organizations market, 2015 - 2026 (USD Million)
Fig. 85 New Zealand pharmaceutical & biotechnological companies market, 2015 - 2026 (USD Million)
Fig. 86 Australia SWOT analysis, by factor (political & legal, economic and technological)
Fig. 87 New Zealand SWOT analysis, by factor (political & legal, economic and technological)